Listed

Biovie Inc.

BIVINasdaqCIK 1580149HealthcareFiscal year ends Jun 30

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$5.7m, Q4 FY2026
Net income−$5.6m, Q4 FY2026
Biovie Inc., income statement, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m8.9Research and development, Q1 FY2024, three months to 2023-09-30$8.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure6.5Research and development, Q2 FY2024, three months to 2023-12-31$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-11, accession 0001520138-25-000056.Report this figure5.7Research and development, Q3 FY2024, three months to 2024-03-31$5.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure2.1Research and development, Q4 FY2024, three months to 2024-06-30$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-08-15, accession 0001520138-25-000268. Derived: 12-month figure less the 9-month figure.Report this figure2.0Research and development, Q1 FY2025, three months to 2024-09-30$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure4.7Research and development, Q2 FY2025, three months to 2024-12-31$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure1.3Research and development, Q3 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure1.2Research and development, Q4 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-08-13, accession 0001520138-26-000332. Derived: 12-month figure less the 9-month figure.Report this figure2.9Research and development, Q1 FY2026, three months to 2025-09-30$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure4.3Research and development, Q2 FY2026, three months to 2025-12-31$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure3.2Research and development, Q3 FY2026, three months to 2026-03-31$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure3.6Research and development, Q4 FY2026, three months to 2026-06-30$3.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-08-13, accession 0001520138-26-000332. Derived: 12-month figure less the 9-month figure.Report this figure
Selling, general and administrative$m1.9Selling, general and administrative, Q1 FY2024, three months to 2023-09-30$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure2.3Selling, general and administrative, Q2 FY2024, three months to 2023-12-31$2.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-02-11, accession 0001520138-25-000056.Report this figure2.0Selling, general and administrative, Q3 FY2024, three months to 2024-03-31$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure2.7Selling, general and administrative, Q4 FY2024, three months to 2024-06-30$2.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-08-15, accession 0001520138-25-000268. Derived: 12-month figure less the 9-month figure.Report this figure2.1Selling, general and administrative, Q1 FY2025, three months to 2024-09-30$2.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure2.5Selling, general and administrative, Q2 FY2025, three months to 2024-12-31$2.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-02-11, accession 0001520138-25-000056.Report this figure1.6Selling, general and administrative, Q3 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure2.4Selling, general and administrative, Q4 FY2025, three months to 2025-06-30$2.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-08-15, accession 0001520138-25-000268. Derived: 12-month figure less the 9-month figure.Report this figure2.3Selling, general and administrative, Q1 FY2026, three months to 2025-09-30$2.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figurenot reportednot reportednot reported
Operating income$m(10.9)Operating income, Q1 FY2024, three months to 2023-09-30−$10.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure(8.8)Operating income, Q2 FY2024, three months to 2023-12-31−$8.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-11, accession 0001520138-25-000056.Report this figure(7.7)Operating income, Q3 FY2024, three months to 2024-03-31−$7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure(4.8)Operating income, Q4 FY2024, three months to 2024-06-30−$4.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-08-15, accession 0001520138-25-000268. Derived: 12-month figure less the 9-month figure.Report this figure(4.1)Operating income, Q1 FY2025, three months to 2024-09-30−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure(7.3)Operating income, Q2 FY2025, three months to 2024-12-31−$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure(3.0)Operating income, Q3 FY2025, three months to 2025-03-31−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure(3.7)Operating income, Q4 FY2025, three months to 2025-06-30−$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-13, accession 0001520138-26-000332. Derived: 12-month figure less the 9-month figure.Report this figure(5.3)Operating income, Q1 FY2026, three months to 2025-09-30−$5.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure(6.3)Operating income, Q2 FY2026, three months to 2025-12-31−$6.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure(5.4)Operating income, Q3 FY2026, three months to 2026-03-31−$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure(5.7)Operating income, Q4 FY2026, three months to 2026-06-30−$5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-13, accession 0001520138-26-000332. Derived: 12-month figure less the 9-month figure.Report this figure
Interest expense$m1.0Interest expense, Q1 FY2024, three months to 2023-09-30$1.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure0.8Interest expense, Q2 FY2024, three months to 2023-12-31$820.6k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-02-13, accession 0001520138-24-000069.Report this figure0.6Interest expense, Q3 FY2024, three months to 2024-03-31$628.7k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-14, accession 0001520138-24-000204.Report this figure0.4Interest expense, Q4 FY2024, three months to 2024-06-30$439.9k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-09-30, accession 0001520138-24-000324. Derived: 12-month figure less the 9-month figure.Report this figure0.3Interest expense, Q1 FY2025, three months to 2024-09-30$256.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure0.1Interest expense, Q2 FY2025, three months to 2024-12-31$66.7k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-03-31$5.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-06-30$5.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-08-13, accession 0001520138-26-000332. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2025-09-30$2.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure0.0Interest expense, Q2 FY2026, three months to 2025-12-31$6.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure0.0Interest expense, Q3 FY2026, three months to 2026-03-31$6.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure0.0Interest expense, Q4 FY2026, three months to 2026-06-30$4.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-08-13, accession 0001520138-26-000332. Derived: 12-month figure less the 9-month figure.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(10.7)Net income, Q1 FY2024, three months to 2023-09-30−$10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure(8.4)Net income, Q2 FY2024, three months to 2023-12-31−$8.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure(8.1)Net income, Q3 FY2024, three months to 2024-03-31−$8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure(4.9)Net income, Q4 FY2024, three months to 2024-06-30−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-08-15, accession 0001520138-25-000268. Derived: 12-month figure less the 9-month figure.Report this figure(4.2)Net income, Q1 FY2025, three months to 2024-09-30−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure(7.1)Net income, Q2 FY2025, three months to 2024-12-31−$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure(2.8)Net income, Q3 FY2025, three months to 2025-03-31−$2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure(3.5)Net income, Q4 FY2025, three months to 2025-06-30−$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-13, accession 0001520138-26-000332. Derived: 12-month figure less the 9-month figure.Report this figure(5.1)Net income, Q1 FY2026, three months to 2025-09-30−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure(6.1)Net income, Q2 FY2026, three months to 2025-12-31−$6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure(5.3)Net income, Q3 FY2026, three months to 2026-03-31−$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure(5.6)Net income, Q4 FY2026, three months to 2026-06-30−$5.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-13, accession 0001520138-26-000332. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share(2.92)Diluted EPS, Q1 FY2024, three months to 2023-09-30−$2.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure(2.20)Diluted EPS, Q2 FY2024, three months to 2023-12-31−$2.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-11, accession 0001520138-25-000056.Report this figure(2.00)Diluted EPS, Q3 FY2024, three months to 2024-03-31−$2.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figurenot reported(7.00)Diluted EPS, Q1 FY2025, three months to 2024-09-30−$7.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure(4.55)Diluted EPS, Q2 FY2025, three months to 2024-12-31−$4.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure(1.51)Diluted EPS, Q3 FY2025, three months to 2025-03-31−$1.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figurenot reported(0.98)Diluted EPS, Q1 FY2026, three months to 2025-09-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure(0.77)Diluted EPS, Q2 FY2026, three months to 2025-12-31−$0.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure(0.70)Diluted EPS, Q3 FY2026, three months to 2026-03-31−$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figurenot reported
Basic EPS$ per share(2.92)Basic EPS, Q1 FY2024, three months to 2023-09-30−$2.92 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure(2.20)Basic EPS, Q2 FY2024, three months to 2023-12-31−$2.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-11, accession 0001520138-25-000056.Report this figure(2.00)Basic EPS, Q3 FY2024, three months to 2024-03-31−$2.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figurenot reported(7.00)Basic EPS, Q1 FY2025, three months to 2024-09-30−$7.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure(4.55)Basic EPS, Q2 FY2025, three months to 2024-12-31−$4.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure(1.51)Basic EPS, Q3 FY2025, three months to 2025-03-31−$1.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figurenot reported(0.98)Basic EPS, Q1 FY2026, three months to 2025-09-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure(0.77)Basic EPS, Q2 FY2026, three months to 2025-12-31−$0.77 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure(0.70)Basic EPS, Q3 FY2026, three months to 2026-03-31−$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figurenot reported

Balance sheet

Cash and equivalents$9.0m, FY2026
Shareholders' equity$10.3m, FY2026
Biovie Inc., balance sheet, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31FY20262026-06-30
Cash and equivalents$m21.2Cash and equivalents, Q1 FY2024, at 2023-09-30$21.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001520138-23-000473.Report this figure20.2Cash and equivalents, Q2 FY2024, at 2023-12-31$20.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-13, accession 0001520138-24-000069.Report this figure30.4Cash and equivalents, Q3 FY2024, at 2024-03-31$30.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001520138-24-000204.Report this figure23.8Cash and equivalents, FY2024, at 2024-06-30$23.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-08-15, accession 0001520138-25-000268.Report this figure20.0Cash and equivalents, Q1 FY2025, at 2024-09-30$20.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure24.4Cash and equivalents, Q2 FY2025, at 2024-12-31$24.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-11, accession 0001520138-25-000056.Report this figure23.2Cash and equivalents, Q3 FY2025, at 2025-03-31$23.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure17.5Cash and equivalents, FY2025, at 2025-06-30$17.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure25.0Cash and equivalents, Q1 FY2026, at 2025-09-30$25.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure20.5Cash and equivalents, Q2 FY2026, at 2025-12-31$20.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure13.1Cash and equivalents, Q3 FY2026, at 2026-03-31$13.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure9.0Cash and equivalents, FY2026, at 2026-06-30$9.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure
Current assets$m22.8Current assets, Q1 FY2024, at 2023-09-30$22.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001520138-23-000473.Report this figure20.6Current assets, Q2 FY2024, at 2023-12-31$20.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-13, accession 0001520138-24-000069.Report this figure30.5Current assets, Q3 FY2024, at 2024-03-31$30.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001520138-24-000204.Report this figure24.0Current assets, FY2024, at 2024-06-30$24.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-08-15, accession 0001520138-25-000268.Report this figure20.2Current assets, Q1 FY2025, at 2024-09-30$20.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure24.7Current assets, Q2 FY2025, at 2024-12-31$24.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-11, accession 0001520138-25-000056.Report this figure23.7Current assets, Q3 FY2025, at 2025-03-31$23.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure20.7Current assets, FY2025, at 2025-06-30$20.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure26.0Current assets, Q1 FY2026, at 2025-09-30$26.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure21.8Current assets, Q2 FY2026, at 2025-12-31$21.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure16.9Current assets, Q3 FY2026, at 2026-03-31$16.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure13.6Current assets, FY2026, at 2026-06-30$13.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure
Total assets$m23.8Total assets, Q1 FY2024, at 2023-09-30$23.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001520138-23-000473.Report this figure21.5Total assets, Q2 FY2024, at 2023-12-31$21.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-13, accession 0001520138-24-000069.Report this figure31.8Total assets, Q3 FY2024, at 2024-03-31$31.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001520138-24-000204.Report this figure25.2Total assets, FY2024, at 2024-06-30$25.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-08-15, accession 0001520138-25-000268.Report this figure21.2Total assets, Q1 FY2025, at 2024-09-30$21.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure25.7Total assets, Q2 FY2025, at 2024-12-31$25.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-11, accession 0001520138-25-000056.Report this figure24.7Total assets, Q3 FY2025, at 2025-03-31$24.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure21.6Total assets, FY2025, at 2025-06-30$21.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure26.8Total assets, Q1 FY2026, at 2025-09-30$26.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure22.5Total assets, Q2 FY2026, at 2025-12-31$22.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure17.5Total assets, Q3 FY2026, at 2026-03-31$17.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure14.3Total assets, FY2026, at 2026-06-30$14.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure
Current liabilities$m13.2Current liabilities, Q1 FY2024, at 2023-09-30$13.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001520138-23-000473.Report this figure14.0Current liabilities, Q2 FY2024, at 2023-12-31$14.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-13, accession 0001520138-24-000069.Report this figure12.5Current liabilities, Q3 FY2024, at 2024-03-31$12.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001520138-24-000204.Report this figure9.4Current liabilities, FY2024, at 2024-06-30$9.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-08-15, accession 0001520138-25-000268.Report this figure6.8Current liabilities, Q1 FY2025, at 2024-09-30$6.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure1.5Current liabilities, Q2 FY2025, at 2024-12-31$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-11, accession 0001520138-25-000056.Report this figure2.5Current liabilities, Q3 FY2025, at 2025-03-31$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure2.3Current liabilities, FY2025, at 2025-06-30$2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure1.6Current liabilities, Q1 FY2026, at 2025-09-30$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure3.0Current liabilities, Q2 FY2026, at 2025-12-31$3.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure1.7Current liabilities, Q3 FY2026, at 2026-03-31$1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure3.8Current liabilities, FY2026, at 2026-06-30$3.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure
Total liabilities$m16.2Total liabilities, Q1 FY2024, at 2023-09-30$16.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001520138-23-000473.Report this figure14.0Total liabilities, Q2 FY2024, at 2023-12-31$14.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-13, accession 0001520138-24-000069.Report this figure12.8Total liabilities, Q3 FY2024, at 2024-03-31$12.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001520138-24-000204.Report this figure9.7Total liabilities, FY2024, at 2024-06-30$9.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-08-15, accession 0001520138-25-000268.Report this figure7.2Total liabilities, Q1 FY2025, at 2024-09-30$7.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure1.8Total liabilities, Q2 FY2025, at 2024-12-31$1.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-11, accession 0001520138-25-000056.Report this figure2.8Total liabilities, Q3 FY2025, at 2025-03-31$2.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure2.6Total liabilities, FY2025, at 2025-06-30$2.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure1.9Total liabilities, Q1 FY2026, at 2025-09-30$1.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure3.2Total liabilities, Q2 FY2026, at 2025-12-31$3.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure1.9Total liabilities, Q3 FY2026, at 2026-03-31$1.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure4.0Total liabilities, FY2026, at 2026-06-30$4.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m7.5Shareholders' equity, Q1 FY2024, at 2023-09-30$7.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure7.5Shareholders' equity, Q2 FY2024, at 2023-12-31$7.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure18.9Shareholders' equity, Q3 FY2024, at 2024-03-31$18.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure15.5Shareholders' equity, FY2024, at 2024-06-30$15.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure14.1Shareholders' equity, Q1 FY2025, at 2024-09-30$14.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure23.9Shareholders' equity, Q2 FY2025, at 2024-12-31$23.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure21.8Shareholders' equity, Q3 FY2025, at 2025-03-31$21.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure19.0Shareholders' equity, FY2025, at 2025-06-30$19.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure24.9Shareholders' equity, Q1 FY2026, at 2025-09-30$24.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure19.3Shareholders' equity, Q2 FY2026, at 2025-12-31$19.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure15.6Shareholders' equity, Q3 FY2026, at 2026-03-31$15.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure10.3Shareholders' equity, FY2026, at 2026-06-30$10.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure

Cash flow

Operating cash flow−$4.1m, Q4 FY2026
Biovie Inc., cash flow, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Operating cash flow$m(12.2)Operating cash flow, Q1 FY2024, three months to 2023-09-30−$12.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure(5.9)Operating cash flow, Q2 FY2024, three months to 2023-12-31−$5.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-11, accession 0001520138-25-000056. Derived: 6-month figure less the 3-month figure.Report this figure(5.9)Operating cash flow, Q3 FY2024, three months to 2024-03-31−$5.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001520138-25-000144. Derived: 9-month figure less the 6-month figure.Report this figure(4.0)Operating cash flow, Q4 FY2024, three months to 2024-06-30−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-08-15, accession 0001520138-25-000268. Derived: 12-month figure less the 9-month figure.Report this figure(3.6)Operating cash flow, Q1 FY2025, three months to 2024-09-30−$3.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure(8.6)Operating cash flow, Q2 FY2025, three months to 2024-12-31−$8.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-06, accession 0001520138-26-000052. Derived: 6-month figure less the 3-month figure.Report this figure(1.3)Operating cash flow, Q3 FY2025, three months to 2025-03-31−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001520138-26-000154. Derived: 9-month figure less the 6-month figure.Report this figure(5.6)Operating cash flow, Q4 FY2025, three months to 2025-06-30−$5.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-13, accession 0001520138-26-000332. Derived: 12-month figure less the 9-month figure.Report this figure(3.0)Operating cash flow, Q1 FY2026, three months to 2025-09-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure(4.4)Operating cash flow, Q2 FY2026, three months to 2025-12-31−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-06, accession 0001520138-26-000052. Derived: 6-month figure less the 3-month figure.Report this figure(7.4)Operating cash flow, Q3 FY2026, three months to 2026-03-31−$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001520138-26-000154. Derived: 9-month figure less the 6-month figure.Report this figure(4.1)Operating cash flow, Q4 FY2026, three months to 2026-06-30−$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-13, accession 0001520138-26-000332. Derived: 12-month figure less the 9-month figure.Report this figure

Shares

Diluted shares (weighted)7.54m, Q3 FY2026
Biovie Inc., shares, quarterly
Line itemUnitQ3 FY20232022-09-30Q2 FY20232022-12-31Q3 FY20232023-03-31Q1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31
Diluted shares (weighted)m shares27.2Diluted shares (weighted), Q3 FY2023, three months to 2022-09-3027,212,445 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001520138-23-000473.Report this figure31.2Diluted shares (weighted), Q2 FY2023, three months to 2022-12-3131,168,826 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-13, accession 0001520138-24-000069.Report this figure35.3Diluted shares (weighted), Q3 FY2023, three months to 2023-03-3135,325,580 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001520138-24-000204.Report this figure3.7Diluted shares (weighted), Q1 FY2024, three months to 2023-09-303,672,490 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001520138-24-000425.Report this figure3.8Diluted shares (weighted), Q2 FY2024, three months to 2023-12-313,817,077 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-11, accession 0001520138-25-000056.Report this figure4.5Diluted shares (weighted), Q3 FY2024, three months to 2024-03-314,480,108 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001520138-25-000144.Report this figure0.6Diluted shares (weighted), Q1 FY2025, three months to 2024-09-30639,836 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure1.6Diluted shares (weighted), Q2 FY2025, three months to 2024-12-311,571,725 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure1.9Diluted shares (weighted), Q3 FY2025, three months to 2025-03-311,850,722 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure5.2Diluted shares (weighted), Q1 FY2026, three months to 2025-09-305,214,355 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001520138-25-000343.Report this figure7.9Diluted shares (weighted), Q2 FY2026, three months to 2025-12-317,920,795 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-06, accession 0001520138-26-000052.Report this figure7.5Diluted shares (weighted), Q3 FY2026, three months to 2026-03-317,543,923 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001520138-26-000154.Report this figure

Shares outstanding: 7.54mShares outstanding, period not labelled, at 2026-08-107,542,638 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-K filed 2026-08-13, accession 0001520138-26-000332.Report this figure at Aug 10, 2026, from the cover of the 10-K filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. Listed shows no prices and gives no investment advice.